Epsilon M&A Deal Report - Dutch Ophthalmic Research Center International (DORC)

Transaction Multiples for the Valuation of Private Companies

Carl Zeiss Meditec > Dutch Ophthalmic Research Center International (DORC)

Announced Date : 15 December 2023

Type : Exit ,Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Carl Zeiss Meditec

Target: Dutch Ophthalmic Research Center International (DORC)

Target Country: Netherlands

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Established in 1983, Dutch Ophthalmic Research Center (DORC) specializes in the developmen ...

No EMAT : 119224

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating **

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1235

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
17/11/2021	Private Group led by ArchiMed	Cardioline	Italy	**
13/07/2024	Private Group backed by Qualium Investissement	IMPC (Imagerie Médicale Paris Centre)	France	*

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database